1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > Generic Drug Analysis & Statistics, January 2016 (p2)

Generic Drug Analysis & Statistics, January 2016 (p2)

31-53 of 53 reports

Purchase Reports From Reputable Market Research Publishers

Fipronil export analysis (12 issues per year)

Fipronil export analysis (12 issues per year)

  • $ 5400
  • Industry report
  • January 2016
  • by CCM Information Science & Technology Co., Ltd

DESCRIPTION This subscription is a monthly report on exports of Fipronil from China based on raw data obtained from the China Customs. To ensure users have everything they need to make effective business ...

  • Industries : Generic Drug
  • Countries : China
Generics: Global Group of Eight (G8) Industry Guide

Generics: Global Group of Eight (G8) Industry Guide

  • $ 1495
  • Industry report
  • January 2016
  • by MarketLine

Introduction The G8 Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains ...

  • Industries : Pharmaceutical
  • Countries : Europe
Apotex, Inc.

Apotex, Inc.

  • $ 175
  • Company report
  • November 2015
  • by MarketLine

Apotex, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings ...

  • Countries : Canada
Generic Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue

Generic Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue

  • $ 1200
  • Industry report
  • November 2015
  • by International Market Analysis Research and Consult

A generic drug is a pharmaceutical product that can be interchanged with the innovator product and is comparable with it in terms of dosage, intended use and efficacy. Generic drugs are manufactured without ...

  • Industries : Generic Drug
  • Countries : World
Medical Affairs Reputations (EU5): Rheumatoid Arthritis

Medical Affairs Reputations (EU5): Rheumatoid Arthritis

  • $ 7370
  • Industry report
  • November 2015
  • by Firstword Pharma

Is your rheumatoid arthritis Medical Affairs team leading the pack or following behind?  How well are the Medical Affairs teams from biosimilar manufacturers performing when compared with those from ...

  • Industries : Generic Drug
  • Countries : United States
The 2016-2021 Outlook for Over-The-Counter Generic Drugs in the United States

The 2016-2021 Outlook for Over-The-Counter Generic Drugs in the United States

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for over-the-counter generic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Generic Drug
  • Countries : United States
The 2016-2021 Outlook for Generic Prescription Drugs in the United States

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic prescription drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Generic Drug
  • Countries : United States
The 2016-2021 Outlook for Generic Drugs in the United States

The 2016-2021 Outlook for Generic Drugs in the United States

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Generic Drug
  • Countries : United States
The 2016-2021 Outlook for Generic Prescription Drugs in India

The 2016-2021 Outlook for Generic Prescription Drugs in India

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic prescription drugs across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Generic Drug
  • Countries : India
The 2016-2021 Outlook for Over-The-Counter Generic Drugs in India

The 2016-2021 Outlook for Over-The-Counter Generic Drugs in India

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for over-the-counter generic drugs across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Generic Drug
  • Countries : India
The 2016-2021 Outlook for Generic Drugs in India

The 2016-2021 Outlook for Generic Drugs in India

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic drugs across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Generic Drug
  • Countries : India
The 2016-2021 Outlook for Over-The-Counter Generic Drugs in Greater China

The 2016-2021 Outlook for Over-The-Counter Generic Drugs in Greater China

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for over-the-counter generic drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, ...

  • Industries : Generic Drug
  • Countries : China
The 2016-2021 Outlook for Generic Prescription Drugs in Greater China

The 2016-2021 Outlook for Generic Prescription Drugs in Greater China

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic prescription drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, ...

  • Industries : Generic Drug
  • Countries : China
The 2016-2021 Outlook for Generic Drugs in Greater China

The 2016-2021 Outlook for Generic Drugs in Greater China

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for generic drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - ...

  • Industries : Generic Drug
  • Countries : China
Indian Generic Drug Market Outlook 2020

Indian Generic Drug Market Outlook 2020

  • $ 800
  • Industry report
  • September 2015
  • by RNCOS

Generics drugs are bioequivalent versions of the originator medicines. These drugs are cheaper and offer similar health benefits as those of branded counterparts. Generics are showing high penetration ...

  • Industries : Generic Drug
  • Countries : India
Detailed I/E report of Fipronil export analysis

Detailed I/E report of Fipronil export analysis

  • $ 5400
  • Industry report
  • July 2015
  • by CCM Information Science & Technology Co., Ltd

Fipronil export analysis will help clients understandthe export situation of technical and formulations with exclusive research methods and offer not only the products’export volume, price, time, source ...

  • Industries : Generic Drug
The 2016-2021 World Outlook for Generic Drugs

The 2016-2021 World Outlook for Generic Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Generic Drug
The 2016-2021 World Outlook for Generic Prescription Drugs

The 2016-2021 World Outlook for Generic Prescription Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for generic prescription drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Generic Drug
The 2016-2021 World Outlook for Over-The-Counter Generic Drugs

The 2016-2021 World Outlook for Over-The-Counter Generic Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for over-the-counter generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Generic Drug
Generic Drugs Market in Japan 2015-2019

Generic Drugs Market in Japan 2015-2019

  • $ 2500
  • Industry report
  • February 2015
  • by Infiniti Research Limited

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Japan
Generic Medical Devices, Inc. - Medical Equipment - Deals and Alliances Profile

Generic Medical Devices, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2014
  • by GlobalData

Summary Generic Medical Devices, Inc. (GMD) is a medical device company, based in the US. The company provides viable medical devices. It designs and develops urology devices for patients, families and ...

  • Industries : Medical Device
  • Countries : United States
Fumarate De Formoterol-Drug Insights,2014

Fumarate De Formoterol-Drug Insights,2014

  • $ 1000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight’s pharmaceuticals report, “Fumarate De Formoterol - Drug Insights, 2014” provides Fumarate De Formoterol marketed details and API Manufacturers details across the globe along with the ...

  • Industries : Generic Drug
  • Countries : United States
The US Pharmacy Benefit Management (PBM) Industry Report: 2013 Edition

The US Pharmacy Benefit Management (PBM) Industry Report: 2013 Edition

  • $ 800
  • Industry report
  • February 2014
  • by Koncept Analytics

In the US, a third party administrator of prescription drug program is known as a Pharmacy Benefit Manager (PBM). The primary responsibilities of a PBM include processing and paying prescriptions drug ...

  • Industries : Pharmaceutical, Healthcare, Pharmacies and Drug Stores
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.